No Data
No Data
Investors Don't See Light At End Of Spruce Biosciences, Inc.'s (NASDAQ:SPRB) Tunnel And Push Stock Down 26%
Express News | Spruce Biosciences: Under Asset Purchase Agreement, Co to Acquire Transferred Assets From Eiger for $10.0 Mln Subject to Certain Circumstances
Express News | Spruce Biosciences : On June 17, an Auction Was Conducted With Respect to Transferred Assets as Part of Eiger's Court-Supervised Sale Process
Express News | Spruce Biosciences- Agreed to Buy All Rights,Title,Interests in,to & Under Some Assets,Interests Used by Eiger BioPharmaceuticals Related to Avexitide
Express News | Spruce Biosciences Inc: On June 13, Co Entered Into a "Stalking Horse" Asset Purchase Agreement
Oppenheimer Maintains Spruce Biosciences(SPRB.US) With Buy Rating, Cuts Target Price to $3